Dumesnil Simon
SEC CIK 1875691 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KTTA | Pasithea Therapeutics Corp. | Dir | 35.8K | $25.0K | — | 2 | 2022-11-15 | 2025-11-28 |
Most active insiders at KTTA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | STEINMAN LAWRENCE | Dir | $100.0K | — |
| 2 | Coastlands Capital LP | 10% | $53.0K | — |
| 3 | Dumesnil Simon | Dir | $25.0K | — |
| 4 | Marques Tiago | CEO, Dir | $25.0K | — |
| 5 | Leahy Emer | Dir | — | — |
| 6 | Schneiderman Daniel H | CFO | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-01 | 2025-11-28 | KTTA | Pasithea Therapeutics Corp. | Dumesnil Simon | Dir | P - Purchase | $0.75 | +33.3K | 35.8K | +1,333% | +$25.0K | |
| DM | 2022-11-17 | 2022-11-15+ | KTTA | Pasithea Therapeutics Corp. | Dumesnil Simon | Dir | A - Grant | $1.06 | +50.0K | 50.0K | New | +$53.1K |
Purchase Sale Sale after option exercise All abbreviations